Zhejiang Benli Technology Co. Ltd. (301065) - Total Liabilities
Based on the latest financial reports, Zhejiang Benli Technology Co. Ltd. (301065) has total liabilities worth CN¥241.20 Million CNY (≈ $35.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Zhejiang Benli Technology Co. Ltd. to track the company's year-over-year net asset growth rate.
Zhejiang Benli Technology Co. Ltd. - Total Liabilities Trend (2019–2025)
This chart illustrates how Zhejiang Benli Technology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See 301065 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Zhejiang Benli Technology Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Zhejiang Benli Technology Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BlackRock Municipal Income Quality Closed Fund
NYSE:BYM
|
USA | $202.55 Million |
|
Hagag Europe Development ZF Ltd
TA:HGGE
|
Israel | ILA196.38 Million |
|
Green Cross
KO:005250
|
Korea | ₩2.40 Trillion |
|
Legato Merger Corp. III
NYSE MKT:LEGT
|
USA | $7.04 Million |
|
Invesco Municipal Income Opportunities Closed Fund Class Common
NYSE:OIA
|
USA | $130.85 Million |
|
XiAn Qujiang Cultural Tourism Co Ltd
SHG:600706
|
China | CN¥2.13 Billion |
|
Federal-Mogul Goetze (India) Limited.
NSE:FMGOETZE
|
India | Rs4.95 Billion |
|
Iochpe-Maxion S.A
SA:MYPK3
|
Brazil | R$9.78 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Zhejiang Benli Technology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Zhejiang Benli Technology Co. Ltd. worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Benli Technology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Benli Technology Co. Ltd. (2019–2025)
The table below shows the annual total liabilities of Zhejiang Benli Technology Co. Ltd. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥279.13 Million ≈ $40.85 Million |
-12.05% |
| 2024-12-31 | CN¥317.36 Million ≈ $46.44 Million |
+62.66% |
| 2023-12-31 | CN¥195.10 Million ≈ $28.55 Million |
+32.24% |
| 2022-12-31 | CN¥147.54 Million ≈ $21.59 Million |
+1.83% |
| 2021-12-31 | CN¥144.89 Million ≈ $21.20 Million |
-13.57% |
| 2020-12-31 | CN¥167.63 Million ≈ $24.53 Million |
+5.78% |
| 2019-12-31 | CN¥158.47 Million ≈ $23.19 Million |
-- |
About Zhejiang Benli Technology Co. Ltd.
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hy… Read more